Skip to main content
    H

    Hims Hers Health Inc (HIMS)

    Official site

    HEALTHCARE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $18.55
    -1.18 (-5.98%)

    Market Cap: $4.62B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Hims Hers Health Inc (HIMS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    Hims Hers Health reported revenue of $2.35B for the fiscal year ended Dec 31, 2025, up 59.0% from the year before. That year, net income was $128.37M with a net margin of 5.5%, operating cash flow was $300.01M and free cash flow was $57.41M. The quarter ended Sep 30, 2026 had revenue of $890.37M and net income of -$33.04M.

    Revenue and Margins

    The operating margin was 4.5% in the fiscal year ended Dec 2025, the highest of the 7 years shown with an operating margin. Over the 7 years to Dec 2025, revenue grew from $26.68M, a compound annual rate of 89.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.35B+59.0%73.8%4.5%5.5%
    Dec 2024$1.48B+69.3%79.5%4.2%8.5%
    Dec 2023$872.00M+65.5%82.0%-3.4%-2.7%
    Dec 2022$526.92M+93.8%77.6%-13.0%-12.5%
    Dec 2021$271.88M+82.8%75.2%-42.3%-39.6%
    Dec 2020$148.76M+80.2%73.6%-10.2%-12.2%
    Dec 2019$82.56M+209.4%54.0%-90.1%-87.3%
    Dec 2018$26.68MN/A29.2%-284.0%-282.0%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 1.8% from the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$2.35B$1.48B$872.00M$526.92M$271.88M$148.76M$82.56M$26.68M
    Cost of revenue$614.26M$303.38M$157.05M$118.19M$67.38M$39.31M$37.95M$18.88M
    Gross profit$1.73B$1.17B$714.95M$408.72M$204.49M$109.45M$44.60M$7.80M
    Research and development$149.30M$78.82M$48.23M$29.24M$22.38M$11.24M$0$0
    Operating income$105.61M$61.90M-$29.45M-$68.70M-$115.04M-$15.14M-$74.41M-$75.77M
    Net income$128.37M$126.04M-$23.55M-$65.68M-$107.66M-$18.11M-$72.06M-$75.24M
    EBITDA$180.92M$84.44M-$17.74M-$58.09M-$104.41MN/A-$71.47MN/A
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$890.37M$753.21M$608.10M$617.82M$598.98M$544.83M$586.01M$481.14M$401.56M$315.65M$278.17M$246.62M
    Gross profit$509.20M$480.80M$396.79M$444.44M$442.06M$416.20M$430.69M$369.54M$317.89M$256.61M$229.09M$204.06M
    Operating income-$66.15M-$97.19M-$78.32M$9.19M$11.81M$26.72M$57.90M$18.60M$22.37M$11.03M$9.90M-$400.00K
    Net income-$33.04M-$86.29M-$92.11M$20.60M$15.77M$42.51M$49.48M$26.02M$75.59M$13.30M$11.13M$1.25M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $977.42M exceeded cash and equivalents by $748.81M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$2.15B$707.54M$441.19M$366.34M$420.58M$118.70M$204.77M$47.52M
    Current assets$767.64M$395.83M$265.05M$216.59M$269.90M$113.08M$1.66M$47.34M
    Cash and equivalents$228.62M$220.58M$96.66M$46.77M$71.78M$27.34M$1.51M$41.50M
    Total liabilities$1.61B$230.82M$97.16M$54.60M$85.97M$15.61M$8.17M$24.73M
    Short-term debt$4.84M$0$7.41M$0$42.83M$0$1.51M$7.78M
    Long-term debt$972.58M$0N/AN/AN/AN/AN/AN/A
    Shareholder equity$540.93M$476.72M$344.03M$311.74M$334.62M-$146.87M$5.00M$22.79M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$3.55B$3.63B$2.27B$2.15B$2.23B$1.88B$891.71M$707.54M$602.26M$480.50M$448.11M$441.19M
    Total liabilities$3.19B$3.30B$1.82B$1.61B$1.65B$1.31B$342.45M$230.82M$162.21M$118.53M$103.62M$97.16M
    Cash and equivalents$605.60M$609.81M$222.27M$228.62M$345.78M$1.12B$273.74M$220.58M$165.52M$129.29M$105.24M$96.66M
    Shareholder equity$355.30M$324.07M$446.17M$540.93M$580.98M$562.70M$549.26M$476.72M$440.05M$361.97M$344.48M$344.03M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 19.1% of operating cash flow. Share repurchases came to 156.7% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow$300.01M$251.08M$73.48M-$26.53M-$34.41M-$2.48M-$74.87M-$57.32M
    Capital expenditures$242.59M$52.75M$26.49M$7.25M$5.01M$4.23M$1.79M$8.00K
    Free cash flow$57.41M$198.33M$46.99M-$33.78M-$39.42M-$6.71M-$76.65M-$57.33M
    Dividends paidN/AN/AN/AN/AN/A$1.74MN/AN/A
    Share repurchases$89.96M$83.04M$2.00M$0$34.88M$3.36M$0N/A
    Investing cash flow-$1.02B-$19.05M-$12.11M$34.70M-$156.27M-$39.70M-$39.30M-$8.00K
    Financing cash flow$729.62M-$107.84M-$11.47M-$33.13M$235.04M$47.74M$95.32M$78.15M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$65.39M-$35.94M$89.36M$61.31M$148.72M-$19.12M$109.09M$86.39M$85.27M$53.59M$25.84M$21.98M
    Capital expenditures$39.42M$32.25M$36.32M$63.88M$69.36M$50.31M$59.04M$26.89M$5.88M$6.03M$13.96M$11.20M
    Free cash flow$25.97M-$68.19M$53.03M-$2.57M$79.36M-$69.43M$50.05M$59.50M$79.39M$47.57M$11.88M$10.79M
    Last 12 quarters

    Frequently Asked Questions About HIMS

    What is Hims Hers Health's annual revenue?

    Hims Hers Health reported revenue of $2.35B for the fiscal year ended Dec 31, 2025.

    How fast is Hims Hers Health's revenue growing?

    Revenue was up 59.0% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 64.5%.

    Is Hims Hers Health profitable?

    Yes. Hims Hers Health reported net income of $128.37M for the fiscal year ended Dec 31, 2025, with a net margin of 5.5%.

    How much free cash flow does HIMS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $300.01M minus capital expenditures of $242.59M produced free cash flow of $57.41M.

    How much debt does Hims Hers Health have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $972.58M, short-term debt of $4.84M and cash and equivalents of $228.62M.